ESPERITE N.V. (ESP) WITH CRYOSAVE READY TO STORE MORE THAN A MILLION SAMPLES IN ITS NEW DESIGNED CRYOSTORAGE FACILITY IN GENEVA.
CryoSave has fully equipped this new safe and secure sample storage BioBank in its state-of-the-art central laboratory in Geneva, Switzerland especially designed for optimal cryopreservation of all biological samples and therefore provide peace of mind to institutional clients and families.
Amsterdam, the Netherlands - 13 September 2018
Sample integrity is a significant key to success in biobanking. The collection, processing and storage of biological specimens must comply to a comprehensive quality management and operating procedures to assure that samples are of consistent quality for the intended analyses, study goals or future medical research. Proper control must be monitored by sample tracking and laboratory informatic systems.
That is why CryoSave (Esperite's flagship company) with more than 15 years leading the Stem Cell cryopreservation industry in Europe, strives every day to continue improving its facilities and protocols to ensure the best quality and security in cryopreservation. More than 330'000 parents have placed their trust on us by storing the umbilical cord blood and tissue of their baby.
The new storage facility in Geneva, Switzerland jointly with our facility in Belgium ensures a capacity of cryopreservation for more than millions of samples.
Our closed and fully automated processing system uses the liquid nitrogen vapor storage method that allows frozen sample storage at liquid nitrogen temperatures preventing direct contact for more security.
This innovative design provides storage temperatures in a range of -190 degree Celsius with absolutely no liquid nitrogen in the sample storage space, making the most efficient use of capacity. This technique achieves extreme low temperatures to prevent the loss of genetic diversity in the preserved sample and avoids any risk of cross-contamination.
Our scientists and lab technicians are constantly improving our processing and storage protocols and techniques to increase the quality of the samples we store.
CryoSave's long established professionalism and expertise allows to offer a unique quality stem cell storage service with exclusive advantages.
All of our Laboratories are appropriately licensed and Geneva's facility is accredited with AABB, GMP:Pic/S, OFSP, Swissmedic authorization for autologous and allogeneic transplantations and ISO 9001:2008.
CEO of Esperite Frédéric Amar declares "Our new state-of-the-art storage area allows us a capacity of cryopreservation for more than millions of biological samples to the safest and highest quality. CryoSave is always ahead with the latest in technological advancement as well as cost efficiencies inherent in our large scale, automated and high throughput laboratory in Geneva to ensure peace of mind to families and protect their baby's future health".
ESPERITE is a diversified biotech global group leader in regenerative and precision medicine. Established in 2000, the holding group is headquartered in the Netherlands, listed at Euronext Amsterdam and Paris and operational in over 30 countries.
ESPERITE transforms the power of state-of-the-art technologies and scientific advancements into high quality products that bring the future of medicine to customers today at an affordable price.
To learn more about the ESPERITE Group, or to book an interview with CEO Frédéric Amar: +31 575 548 998 - email@example.com or visit the websites at www.esperite.com , www.genoma.com and www.cryo-save.com .
This press release contains inside information as referred to in article 7 paragraph 1 of Regulation (EU) 596/2014 (Market Abuse Regulation).Biobank Geneva
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Esperite N.V. via GlobeNewswire